Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 20/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17480482 | 0.89 | SLC5A2 (0.69) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 | |
| SCHEMBL12662721 | 0.85 | SLC5A2 (0.50) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 | |
| SCHEMBL12426002 | 0.82 | SLC5A2 (0.78) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 | |
| SCHEMBL16148900 | 0.77 | SLC5A2 (0.45) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 | |
| SCHEMBL16009598 | 0.77 | SLC5A2 (0.45) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 | |
| SCHEMBL19620432 | 0.76 | SLC5A2 (0.70) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 | |
| SCHEMBL17189371 | 0.76 | SLC5A2 (0.70) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 | |
| SCHEMBL17480497 | 0.76 | SLC5A2 (0.70) | SLC5A2 | |
| SCHEMBL17623853 | 0.76 | SLC5A2 (0.70) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 | |
| SCHEMBL17480536 | 0.73 | SLC5A2 (0.56) | SLC5A2CHRM1SLC5A1ADRA1ASLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1609785-B1 | C-GLYCOSIDE DERIVATIVES AND SALTS THEREOF | ASTELLAS PHARMA INC (JP) | 2016-02-03 | — | — | EP | disclosed |